Senators Call on FDA to Act Against Misleading Weight-Loss Drug Commercials
Commercials run by the telehealth company Hims & Hers have been placed under the microscope as lawmakers are calling out ...
Scribeemr Debuts AI Charting With 100% Accuracy At HIMSS
WOBURN, MA, UNITED STATES, February 12, 2025 /EINPresswire / -- ScribeEMR, a leading provider of AI-powered healthcare documentation solution ...
What is compounded semaglutide? All you need to know about the weight loss drugs Hims & Hers is selling
Hims & Hers is under scrutiny for promoting compounded weight-loss drugs in a Super Bowl ad without clear FDA approval or ...
STAT3d
Two biotech companies claim they use AI to design drugs from scratch. Do they?
A federal judge will soon decide whether to dismiss a lawsuit against UnitedHealth Group alleging that the company and its ...
Hims & Hers Super Bowl controversy: What the ad left out about its 'alternative' weight-loss drugs
The telehealth company Hims & Hers put out a Super Bowl ad that skimped on clarifying that its compounded semaglutide medications aren't FDA-approved.
What is compounded semaglutide and is it safe? The more affordable weight loss drugs Hims & Hers is selling, explained.
"They’re priced for profits, not patients.” That’s the critique from Hims & Hers Health’s buzzy — and controversial — Super ...
Weight Loss Drug Super Bowl Ad Raises Questions About Compounded Vs. Branded Meds
An ad airing Super Bowl Sunday features “America’s deadliest epidemic,” obesity, and what can be done about it with the use of “affordable” compounded weight loss drugs.
Is the promise of more affordable weight loss drugs too good to be true? Compounded semaglutide, explained.
Compounded semaglutide is legal, but it's not regulated in the same way as medications like Ozempic and Wegovy.
Money Morning15d
HIMS Shares Seeing Buy the Rumor Rally, This is Their Target
Shares of healthcare company Hims & Hers (HIMS) led the market higher on Friday with gains of almost 8%. The move completes a 50% rally over the last three weeks resulting in new all-time highs ...
Nasdaq15d
Hims & Hers Stock Surges 69.2% in Three Months: What's Next?
Hims & Hers Health, Inc.’s HIMS investors have been experiencing some short-term gains from the stock of late. Shares of the San Francisco, CA-based health and wellness platform have surged 69.2 ...